Status:
RECRUITING
Group Integrative Breathwork for Chronic Pain
Lead Sponsor:
University of Florida
Conditions:
Chronic Pain
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The aim of the proposed research is to iteratively develop, pilot test, and refine an integrative breathwork intervention that is suitable for group delivery to individuals with chronic pain. The inte...
Detailed Description
Multiple single-arm iterations of a group breathwork intervention will be conducted to refine and optimize the intervention and protocol. Upon completion of each iteration, quantitative and qualitativ...
Eligibility Criteria
Inclusion
- Men and women 18-70 years of age.
- Chronic musculoskeletal pain lasting for at least 3 months as a symptom of axial pain (e.g., back, neck) or limb pain (e.g., shoulder, knee, hip, wrist).
- Average pain intensity of ≥ 4/10 for the past month.
- Access to internet with a valid email address
- Able to lay down and stay relatively still for one hour.
Exclusion
- Any suspicion of a medical (orthopedic, rheumatic or neurological) disease, that can fully explain the current level of severity of pain.
- Chronic pain possibly due to specific conditions (e.g., cancer, infection).
- Ongoing legal action or disability claim related to chronic pain.
- Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy, history of seizures) or moderate or severe symptoms from a previous brain injury, including stroke and traumatic brain injury.
- Respiratory disorder (e.g., chronic obstructive pulmonary disease) or moderate to severe asthma within the past 12 months.
- Activity limiting heart disease including cardiovascular or peripheral arterial disease.
- Uncontrolled hypertension (i.e. SBP/DBP of \> 160/95) or orthostatic hypotension (e.g., issues with fainting).
- Serious acute physical injuries or major surgery within the past 6 months.
- Serious psychiatric disorder (e.g., schizophrenia, panic disorder) or mental health issues requiring hospitalization within the past 12 months or currently on antipsychotic medications.
- History of hospitalization or treatment of substance use disorder within the past 12 months.
- Currently undergoing curative or palliative chemotherapy or radiation.
- Pregnant.
- Glaucoma or detached retina.
- Current participation or participation in the past 2 months of an interventional research study.
- Cognitive impairment or factors that would preclude comprehension of material and/or full participation in the study.
- Any significant comorbidities or other reasons that, in the opinion of the investigators, could interfere with the study or lead to deleterious effects for the participant.
Key Trial Info
Start Date :
June 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06977984
Start Date
June 18 2025
End Date
April 30 2026
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Clinical Research Center
Gainesville, Florida, United States, 32603